Brain connectivity and patient reported outcomes in people with HIV (PWH) with symptoms of insomnia switching integrase inhibitor-based ART; a randomised controlled study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary) ; Abacavir/dolutegravir/lamivudine
Indications HIV-1 infections
Focus Pharmacodynamics
Acronyms BIC CNS Study

20 Jun 2023 Status changed from active, no longer recruiting to completed.
05 Oct 2022 Recruitment completion is expected on 31 Jan 2023, according to ISRCTN: Current Controlled Trials.
05 Oct 2022 Planned End Date changed from 17 Feb 2023 to 30 Jun 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com